Baird Medical Investment Holdings Limited (BDMD) — Dilution Risk Analysis

Current Snapshot

Baird Medical Investment Holdings Limited (BDMD) has a DilutionWatch score of 84/10 and is classified as CRITICAL risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
40,979,382 Source
Public Float
4,664,622 Source
Float as % of Outstanding
11.4%

Dilution Risk Score

Score: 84/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: SC 13G 1, 6-K 1, EFFECT 2, SC 13D 1, 3 5.

FormFiledAccession
SC 13G 2026-10-01 0001400253-26-000006
6-K 2026-09-30 0001104659-26-112324
EFFECT 2026-08-17 9999999995-26-002677
EFFECT 2026-08-17 9999999995-26-002679
SC 13D 2026-07-31 0001683168-26-005875
3 2026-07-31 0001683168-26-005876
3 2026-04-21 0001104659-26-045650
3 2026-04-21 0001104659-26-045663
3 2026-04-21 0001104659-26-045670
3 2026-04-17 0001104659-26-044857

Dilution Risk Drivers

DriverStored ValueSource
Cash runway 0 months Source
Three-year share count growth 27.19% Source

DilutionWatch Analysis

Risk Level
CRITICAL (Score: 84/10) Source
Cash Runway
0 months Source
Share Count Growth (3-Year)
27.19% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.